| 1 | Rasopathy | Enrichment | BRAF, HRAS, MAP2K1, MAP2K2, RAF1, SOS1, SOS2 | 16.00 |
| 2 | Noonan syndrome 1 | Enrichment | BRAF, HRAS, MAP2K1, MAP2K2, RAF1, SOS1, SOS2 | 11.51 |
| 3 | Noonan syndrome and noonan-related syndrome | Enrichment | BRAF, HRAS, MAP2K1, MAP2K2, RAF1, SOS1 | 11.06 |
| 4 | Lung non-small cell carcinoma | Enrichment | BRAF, EGFR, HRAS, KRAS, MAP2K1, NRAS | 8.97 |
| 5 | Cardiofaciocutaneous syndrome 1 | Enrichment | BRAF, KRAS, MAP2K1, MAP2K2 | 7.74 |
| 6 | Cardiofaciocutaneous syndrome | Enrichment | BRAF, KRAS, MAP2K1, MAP2K2 | 7.74 |
| 7 | Noonan syndrome 3 | Enrichment | HRAS, KRAS, RAF1, SOS1 | 6.21 |
| 8 | Melanocytic nevus syndrome, congenital | Enrichment | BRAF, HRAS, NRAS, RAF1 | 5.91 |
| 9 | Langerhans cell histiocytosis | Enrichment | BRAF, MAP2K1, NRAS | 5.80 |
| 10 | Schimmelpenning-feuerstein-mims syndrome | Enrichment | HRAS, KRAS, NRAS | 5.20 |
| 11 | Deafness, autosomal recessive 1a | Enrichment | GJB2, GJB3, GJB6 | 5.20 |
| 12 | Gjb2-related autosomal recessive nonsyndromic hearing loss | Enrichment | GJB2, GJB3, GJB6 | 5.20 |
| 13 | Pulmonic stenosis | Enrichment | BRAF, SOS1 | 4.86 |
| 14 | Lung cancer susceptibility 3 | Enrichment | ACTA2, BRAF, EGFR, KRAS | 4.78 |
| 15 | Pigmented nodular adrenocortical disease, primary, 1 | Enrichment | GNAS, PRKAR1A | 4.70 |
| 16 | Nevus, epidermal | Enrichment | HRAS, KRAS, NRAS | 4.27 |
| 17 | Thyroid cancer, nonmedullary, 2 | Enrichment | BRAF, HRAS, NRAS | 4.27 |
| 18 | Gallbladder cancer | Enrichment | BRAF, CTNNB1, KRAS | 4.27 |
| 19 | Pilomyxoid astrocytoma | Enrichment | BRAF, KRAS, RAF1 | 4.27 |
| 20 | Follicular thyroid carcinoma | Enrichment | BRAF, HRAS, NRAS | 4.27 |
| 21 | Noonan syndrome with multiple lentigines | Enrichment | BRAF, RAF1 | 4.08 |
| 22 | Erythrokeratodermia variabilis et progressiva 1 | Enrichment | GJA1, GJB3, GJB4 | 4.07 |
| 23 | Ras-associated autoimmune leukoproliferative disorder | Enrichment | KRAS, NRAS | 3.86 |
| 24 | Deafness, autosomal recessive 1b | Enrichment | GJB2, GJB6 | 3.86 |
| 25 | Baraitser-winter cerebrofrontofacial syndrome | Enrichment | ACTB, ACTG1 | 3.86 |
| 26 | Keratitis ichthyosis and deafness syndrome | Enrichment | GJB2, GJB6 | 3.86 |
| 27 | Juvenile myelomonocytic leukemia | Enrichment | KRAS, NRAS, RRAS | 3.49 |
| 28 | Lip and oral cavity carcinoma | Enrichment | BRAF, EGFR, HRAS | 3.49 |
| 29 | Bladder cancer | Enrichment | CTNNB1, EGFR, HRAS, KRAS | 3.46 |
| 30 | Differentiated thyroid carcinoma | Enrichment | BRAF, HRAS, KRAS, NRAS | 3.46 |
| 31 | Rare autosomal dominant non-syndromic sensorineural deafness type dfna | Enrichment | ACTG1, GJB2, GJB3, GJB6, TJP2 | 3.46 |
| 32 | Deafness, x-linked 2 | Enrichment | GJB2, GJB6 | 3.39 |
| 33 | Large congenital melanocytic nevus | Enrichment | HRAS, NRAS | 3.39 |
| 34 | X-linked mixed hearing loss with perilymphatic gusher | Enrichment | GJB2, GJB6 | 3.39 |
| 35 | Tubulinopathy-associated dysgyria | Enrichment | TUBB2B, TUBB3 | 3.39 |
| 36 | Ellis-van creveld syndrome | Enrichment | PRKACA, PRKACB | 3.31 |
| 37 | Arteriovenous malformation | Enrichment | HRAS, MAP2K1 | 3.31 |
| 38 | Lung cancer | Enrichment | ACTA2, BRAF, EGFR, KRAS | 3.30 |
| 39 | Colorectal cancer | Enrichment | AKT1, BRAF, CTNNB1, NRAS, PIK3R1, SRC | 3.26 |
| 40 | Myopathy, x-linked, with excessive autophagy | Enrichment | HRAS, MAP2K1 | 3.21 |
| 41 | Primary hyperaldosteronism | Enrichment | BRAF, GNAS | 3.15 |
| 42 | Auriculocondylar syndrome 1 | Enrichment | GNAI3, PLCB4 | 3.09 |
| 43 | Megalencephaly-capillary malformation-polymicrogyria syndrome | Enrichment | AKT3, PIK3R2 | 3.09 |
| 44 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 | Enrichment | AKT3, PIK3R2 | 3.09 |
| 45 | Chronic myelogenous leukemia, bcr-abl1 positive | Enrichment | KRAS, NRAS | 3.09 |
| 46 | Tubulinopathy | Enrichment | TUBB2A, TUBB2B | 3.09 |
| 47 | Craniopharyngioma | Enrichment | BRAF, CTNNB1 | 3.09 |
| 48 | Acute promyelocytic leukemia | Enrichment | PRKAR1A, STAT3 | 2.98 |
| 49 | Arteriovenous malformations of the brain | Enrichment | BRAF, EGFR, KRAS | 2.87 |
| 50 | Nonsyndromic hearing loss | Enrichment | ACTG1, GJB2, GJB3, GJB6 | 2.84 |
| 51 | Lissencephaly | Enrichment | ACTG1, TUBB2B, TUBB3 | 2.74 |
| 52 | Moyamoya disease 1 | Enrichment | ACTA2, GUCY1A1 | 2.70 |
| 53 | Congenital fibrosis of the extraocular muscles | Enrichment | TUBB2B, TUBB3 | 2.70 |
| 54 | Adrenocortical carcinoma | Enrichment | CTNNB1, PRKAR1A | 2.70 |
| 55 | Breast adenocarcinoma | Enrichment | AKT1, KRAS | 2.70 |
| 56 | Lung squamous cell carcinoma | Enrichment | EGFR, KRAS | 2.70 |
| 57 | Body mass index quantitative trait locus 11 | Enrichment | ADCY3, ADRB3, GNAS | 2.66 |
| 58 | Diffuse large b-cell lymphoma | Enrichment | BRAF, STAT3 | 2.64 |
| 59 | Hypertension, essential | Enrichment | ADD1, GNB3 | 2.59 |
| 60 | Capillary malformation-arteriovenous malformation 1 | Enrichment | KRAS, MAP2K1 | 2.56 |
| 61 | Leukemia, chronic myeloid | Enrichment | KRAS, NRAS | 2.56 |
| 62 | Breast cancer | Enrichment | AKT1, GNG3, SHC1 | 2.55 |
| 63 | Microcephaly | Enrichment | ACTB, ACTG1, CTNNB1, GNB1, GRM7, MAPK1 | 2.49 |
| 64 | Acrodysostosis 1 with or without hormone resistance | Enrichment | PRKAR1A | 2.42 |
| 65 | Noonan syndrome 5 | Enrichment | RAF1 | 2.42 |
| 66 | Noonan syndrome 4 | Enrichment | SOS1 | 2.42 |
| 67 | Lipodystrophy, congenital generalized, type 3 | Enrichment | CAV1 | 2.42 |
| 68 | Carney complex, type 1 | Enrichment | PRKAR1A | 2.42 |
| 69 | Melorheostosis, isolated | Enrichment | MAP2K1 | 2.42 |
| 70 | Noonan syndrome 7 | Enrichment | BRAF | 2.42 |
| 71 | Leopard syndrome 3 | Enrichment | BRAF | 2.42 |
| 72 | Cardiomyopathy, dilated, 1nn | Enrichment | RAF1 | 2.42 |
| 73 | Cardiofaciocutaneous syndrome 3 | Enrichment | MAP2K1 | 2.42 |
| 74 | Noonan syndrome 9 | Enrichment | SOS2 | 2.42 |
| 75 | Neurodevelopmental disorder with involuntary movements | Enrichment | GNAO1 | 2.42 |
| 76 | Deafness, autosomal recessive 44 | Enrichment | ADCY1 | 2.42 |
| 77 | Pulmonary hypertension, primary, 3 | Enrichment | CAV1 | 2.42 |
| 78 | Ventricular tachycardia, familial | Enrichment | GNAI2 | 2.42 |
| 79 | Neurodevelopmental disorder with hypotonia and dysmorphic facies | Enrichment | GNB2 | 2.42 |
| 80 | Noonan syndrome 13 | Enrichment | MAPK1 | 2.42 |
| 81 | Cardioacrofacial dysplasia 2 | Enrichment | PRKACB | 2.42 |
| 82 | T-cell large granular lymphocyte leukemia | Enrichment | STAT3 | 2.42 |
| 83 | Neurodevelopmental disorder with hypotonia, impaired speech, and behavioral abnormalities | Enrichment | GNAI1 | 2.42 |
| 84 | Myxoma, intracardiac | Enrichment | PRKAR1A | 2.42 |
| 85 | Lipodystrophy, familial partial, type 7 | Enrichment | CAV1 | 2.42 |
| 86 | Developmental and epileptic encephalopathy 17 | Enrichment | GNAO1 | 2.42 |
| 87 | Lymphangioma | Enrichment | BRAF | 2.42 |
| 88 | Lodder-merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmia | Enrichment | GNB5 | 2.42 |
| 89 | Phace association | Enrichment | BRAF | 2.42 |
| 90 | Melorheostosis | Enrichment | MAP2K1 | 2.42 |
| 91 | Leopard syndrome 2 | Enrichment | RAF1 | 2.42 |
| 92 | Cardiofaciocutaneous syndrome 4 | Enrichment | MAP2K2 | 2.42 |
| 93 | Pigmented nodular adrenocortical disease, primary, 4 | Enrichment | PRKACA | 2.42 |
| 94 | Charcot-marie-tooth disease, dominant intermediate f | Enrichment | GNB4 | 2.42 |
| 95 | Autoimmune disease, multisystem, infantile-onset, 1 | Enrichment | STAT3 | 2.42 |
| 96 | Cardioacrofacial dysplasia 1 | Enrichment | PRKACA | 2.42 |
| 97 | Thrombocytopenia 6 | Enrichment | SRC | 2.42 |
| 98 | Intellectual developmental disorder, autosomal dominant 42 | Enrichment | GNB1 | 2.42 |
| 99 | Sick sinus syndrome 4 | Enrichment | GNB2 | 2.42 |
| 100 | Trigonitis | Enrichment | RAF1 | 2.42 |
| 101 | Prkar1b-related neurodegenerative dementia with intermediate filaments | Enrichment | PRKAR1B | 2.42 |
| 102 | Stat3-related early-onset multisystem autoimmune disease | Enrichment | STAT3 | 2.42 |
| 103 | Syringocystadenoma papilliferum | Enrichment | BRAF | 2.42 |
| 104 | Ganglioglioma | Enrichment | BRAF | 2.42 |
| 105 | Nongerminomatous germ cell tumor | Enrichment | BRAF | 2.42 |
| 106 | Phace syndrome | Enrichment | BRAF | 2.42 |
| 107 | Gnao1-related disorder | Enrichment | GNAO1 | 2.42 |
| 108 | Phakomatosis pigmentokeratotica | Enrichment | HRAS | 2.42 |
| 109 | Classic hairy cell leukemia | Enrichment | BRAF | 2.42 |
| 110 | Chronic lymphoproliferative disorder of natural killer cells | Enrichment | STAT3 | 2.42 |
| 111 | Proteus syndrome | Enrichment | AKT1 | 2.42 |
| 112 | Hypoinsulinemic hypoglycemia with hemihypertrophy | Enrichment | AKT2 | 2.42 |
| 113 | Charcot-marie-tooth disease, dominant intermediate b | Enrichment | DNM2 | 2.42 |
| 114 | Dyskinesia with orofacial involvement, autosomal dominant | Enrichment | ADCY5 | 2.42 |
| 115 | Ataxia-oculomotor apraxia 3 | Enrichment | PIK3R5 | 2.42 |
| 116 | Neurodevelopmental disorder with hyperkinetic movements and dyskinesia | Enrichment | ADCY5 | 2.42 |
| 117 | Immune dysregulation, autoimmunity, and autoinflammation | Enrichment | PLCG1 | 2.42 |
| 118 | Isolated growth hormone deficiency type iii | Enrichment | BTK | 2.42 |
| 119 | Dyskinesia with orofacial involvement, autosomal recessive | Enrichment | ADCY5 | 2.42 |
| 120 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 | Enrichment | AKT3 | 2.42 |
| 121 | Lethal congenital contracture syndrome 5 | Enrichment | DNM2 | 2.42 |
| 122 | Autoinflammation, antibody deficiency, and immune dysregulation | Enrichment | PLCG2 | 2.42 |
| 123 | Cowden syndrome 6 | Enrichment | AKT1 | 2.42 |
| 124 | Immunodeficiency 97 with autoinflammation | Enrichment | PIK3CG | 2.42 |
| 125 | Familial cold autoinflammatory syndrome 3 | Enrichment | PLCG2 | 2.42 |
| 126 | Autosomal dominant charcot-marie-tooth disease type 2m | Enrichment | DNM2 | 2.42 |
| 127 | Capillary hemangioma | Enrichment | AKT3 | 2.42 |
| 128 | Akt2-related familial partial lipodystrophy | Enrichment | AKT2 | 2.42 |
| 129 | Rare autosomal recessive non-syndromic sensorineural deafness type dfnb | Enrichment | ADCY1, GJA1, GJB2, GJB3, GJB6 | 2.41 |
| 130 | Adenosine triphosphate, elevated, of erythrocytes | Enrichment | PKLR | 2.35 |
| 131 | Anemia, congenital, nonspherocytic hemolytic, 2 | Enrichment | PKLR | 2.35 |
| 132 | Pseudohypoparathyroidism, type ic | Enrichment | GNAS | 2.35 |
| 133 | Osseous heteroplasia, progressive | Enrichment | GNAS | 2.35 |
| 134 | Acth-independent macronodular adrenal hyperplasia 1 | Enrichment | GNAS | 2.35 |
| 135 | Pituitary adenoma 3, multiple types | Enrichment | GNAS | 2.35 |
| 136 | Ferguson-bonni neurodevelopmental syndrome | Enrichment | ANAPC7 | 2.35 |
| 137 | Rothmund-thomson syndrome, type 1 | Enrichment | ANAPC1 | 2.35 |
| 138 | Disorders of gnas inactivation | Enrichment | GNAS | 2.35 |
| 139 | Epilepsy, familial adult myoclonic, 7 | Enrichment | RAPGEF2 | 2.35 |
| 140 | Congenital myopathy with myasthenic-like onset | Enrichment | RYR1 | 2.35 |
| 141 | Monostotic fibrous dysplasia | Enrichment | GNAS | 2.35 |
| 142 | Mazabraud syndrome | Enrichment | GNAS | 2.35 |
| 143 | Calf-predominant weakness-gastrocnemius medialis atrophy-distal myopathy | Enrichment | RYR1 | 2.35 |
| 144 | Benign samaritan congenital myopathy | Enrichment | RYR1 | 2.35 |
| 145 | Adult hepatocellular carcinoma | Enrichment | CTNNB1, EGF | 2.33 |
| 146 | Anhidrosis, isolated, with normal sweat glands | Enrichment | ITPR2 | 2.29 |
| 147 | Resting heart rate, variation in | Enrichment | ADRB1 | 2.29 |
| 148 | Immunodeficiency 64 with lymphoproliferation | Enrichment | RASGRP1 | 2.29 |
| 149 | Charcot-marie-tooth disease, demyelinating, type 1j | Enrichment | ITPR3 | 2.29 |
| 150 | Short sleep, familial natural, 2 | Enrichment | ADRB1 | 2.29 |
| 151 | Immunodeficiency 133 with ectodermal dysplasia with or without peripheral neuropathy | Enrichment | ITPR3 | 2.29 |
| 152 | Immunodeficiency 64 | Enrichment | RASGRP1 | 2.29 |
| 153 | Ebv-induced lymphoproliferative disease due to rasgrp1 deficiency | Enrichment | RASGRP1 | 2.29 |
| 154 | Non-immune hydrops fetalis | Enrichment | ACTA1, HRAS, KRAS | 2.25 |
| 155 | Cataract 30, multiple types | Enrichment | GJA3, GJA8 | 2.24 |
| 156 | Autosomal dominant macrothrombocytopenia | Enrichment | TUBA8, TUBB1 | 2.24 |
| 157 | Ovarian cancer | Enrichment | AKT1, CTNNB1, EGFR, KRAS, RRAS2 | 2.18 |
| 158 | Fibromatosis, gingival, 1 | Enrichment | SOS1 | 2.12 |
| 159 | Costello syndrome | Enrichment | HRAS | 2.12 |
| 160 | Amelogenesis imperfecta, type ig | Enrichment | PRKAR1A | 2.12 |
| 161 | Pituitary adenoma 4, acth-secreting | Enrichment | GNAI2 | 2.12 |
| 162 | Bleeding disorder, platelet-type, 19 | Enrichment | PRKACG | 2.12 |
| 163 | Night blindness, congenital stationary, type 1h | Enrichment | GNB3 | 2.12 |
| 164 | Marbach-schaaf neurodevelopmental syndrome | Enrichment | PRKAR1B | 2.12 |
| 165 | Usher syndrome, type iv | Enrichment | PRKAR1A | 2.12 |
| 166 | Acrodysostosis | Enrichment | PRKAR1A | 2.12 |
| 167 | Fibrolamellar carcinoma | Enrichment | PRKACA | 2.12 |
| 168 | Ciliary dyskinesia, primary, 18 | Enrichment | PRKAR1B | 2.12 |
| 169 | Hypopituitarism | Enrichment | GNAI2 | 2.12 |
| 170 | Lodder-merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmia | Enrichment | GNB5 | 2.12 |
| 171 | Isolated primary pigmented nodular adrenocortical disease | Enrichment | PRKAR1A | 2.12 |
| 172 | Tafro syndrome | Enrichment | MAP2K2 | 2.12 |
| 173 | Cerebral visual impairment | Enrichment | GNB1 | 2.12 |
| 174 | Wooly hair nevus | Enrichment | HRAS | 2.12 |
| 175 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | Enrichment | PIK3R5 | 2.12 |
| 176 | Isolated growth hormone deficiency, type iii, with agammaglobulinemia | Enrichment | BTK | 2.12 |
| 177 | Agammaglobulinemia, x-linked | Enrichment | BTK | 2.12 |
| 178 | Senior-loken syndrome 7 | Enrichment | AKT3 | 2.12 |
| 179 | Bardet-biedl syndrome 16 | Enrichment | AKT3 | 2.12 |
| 180 | Malignant hyperthermia 1 | Enrichment | RYR1 | 2.05 |
| 181 | Pseudohypoparathyroidism, type ia | Enrichment | GNAS | 2.05 |
| 182 | Histiocytoma, angiomatoid fibrous | Enrichment | CREB1 | 2.05 |
| 183 | Pseudopseudohypoparathyroidism | Enrichment | GNAS | 2.05 |
| 184 | King-denborough syndrome | Enrichment | RYR1 | 2.05 |
| 185 | Pseudohypoparathyroidism | Enrichment | GNAS | 2.05 |
| 186 | Anemia, congenital, nonspherocytic hemolytic, 3 | Enrichment | AK1 | 2.05 |
| 187 | Exercise-induced malignant hyperthermia | Enrichment | RYR1 | 2.05 |
| 188 | Acth-independent macronodular adrenal hyperplasia | Enrichment | GNAS | 2.05 |
| 189 | Spinocerebellar ataxia 29 | Enrichment | ITPR1 | 1.99 |
| 190 | Lethal congenital contracture syndrome 8 | Enrichment | ADCY6 | 1.99 |
| 191 | Body mass index quantitative trait locus 19 | Enrichment | ADCY3 | 1.99 |
| 192 | Houge-janssens syndrome 3 | Enrichment | PPP2CA | 1.99 |
| 193 | Hyper-ige syndrome 1, autosomal dominant, with recurrent infections | Enrichment | STAT3 | 1.95 |
| 194 | Ataxia-telangiectasia | Enrichment | BRAF | 1.95 |
| 195 | Nuchal bleb, familial | Enrichment | SOS1 | 1.95 |
| 196 | Tethered spinal cord syndrome | Enrichment | BRAF | 1.95 |
| 197 | Breast implant-associated anaplastic large cell lymphoma | Enrichment | STAT3 | 1.95 |
| 198 | Hyper ige syndrome | Enrichment | STAT3 | 1.95 |
| 199 | Spermatocytoma | Enrichment | HRAS | 1.95 |
| 200 | Agammaglobulinemia 1, autosomal recessive | Enrichment | BTK | 1.95 |
| 201 | Myopathy, centronuclear, x-linked | Enrichment | DNM2 | 1.95 |
| 202 | Agammaglobulinemia 1 | Enrichment | BTK | 1.95 |
| 203 | Palmoplantar keratoderma and congenital alopecia 1 | Enrichment | GJA1 | 1.93 |
| 204 | Bart-pumphrey syndrome | Enrichment | GJB2 | 1.93 |
| 205 | Clouston syndrome | Enrichment | GJB6 | 1.93 |
| 206 | Vohwinkel syndrome | Enrichment | GJB2 | 1.93 |
| 207 | Hypoplastic left heart syndrome 1 | Enrichment | GJA1 | 1.93 |
| 208 | Baraitser-winter syndrome 1 | Enrichment | ACTB | 1.93 |
| 209 | Oculoectodermal syndrome | Enrichment | KRAS | 1.93 |
| 210 | Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement | Enrichment | TUBB3 | 1.93 |
| 211 | Pallister-killian syndrome | Enrichment | ARAF | 1.93 |
| 212 | Cataract 14, multiple types | Enrichment | GJA3 | 1.93 |
| 213 | Hypomagnesemia 4, renal | Enrichment | EGF | 1.93 |
| 214 | Deafness, autosomal dominant 3a | Enrichment | GJB2 | 1.93 |
| 215 | Lymphatic malformation 3 | Enrichment | GJC2 | 1.93 |
| 216 | Deafness, autosomal dominant 51 | Enrichment | TJP2 | 1.93 |
| 217 | Congenital myopathy 2a, typical, autosomal dominant | Enrichment | ACTA1 | 1.93 |
| 218 | Keratitis-ichthyosis-deafness syndrome, autosomal dominant | Enrichment | GJB2 | 1.93 |
| 219 | Oculodentodigital dysplasia | Enrichment | GJA1 | 1.93 |
| 220 | Deafness, autosomal dominant 3b | Enrichment | GJB6 | 1.93 |
| 221 | Cataract 1, multiple types | Enrichment | GJA8 | 1.93 |
| 222 | Nail disorder, nonsyndromic congenital, 3 | Enrichment | PLCD1 | 1.93 |
| 223 | Melanosis, neurocutaneous | Enrichment | NRAS | 1.93 |
| 224 | Macrothrombocytopenia, isolated, 1, autosomal dominant | Enrichment | TUBB1 | 1.93 |
| 225 | Myopathy, scapulohumeroperoneal | Enrichment | ACTA1 | 1.93 |
| 226 | Noonan syndrome 6 | Enrichment | NRAS | 1.93 |
| 227 | Advanced sleep phase syndrome, familial, 2 | Enrichment | CSNK1D | 1.93 |
| 228 | Aortic aneurysm, familial thoracic 8 | Enrichment | PRKG1 | 1.93 |
| 229 | Deafness, autosomal dominant 2b | Enrichment | GJB3 | 1.93 |
| 230 | Spinocerebellar ataxia, autosomal recessive 13 | Enrichment | GRM1 | 1.93 |
| 231 | Craniometaphyseal dysplasia, autosomal recessive | Enrichment | GJA1 | 1.93 |
| 232 | Noonan syndrome 11 | Enrichment | MRAS | 1.93 |
| 233 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 | Enrichment | ACTG2 | 1.93 |
| 234 | Spondylometaphyseal dysplasia, pagnamenta type | Enrichment | PRKG2 | 1.93 |
| 235 | Spondylometaphyseal dysplasia with corneal dystrophy | Enrichment | PLCB3 | 1.93 |
| 236 | Developmental and epileptic encephalopathy 91 | Enrichment | PPP3CA | 1.93 |
| 237 | Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development | Enrichment | PPP3CA | 1.93 |
| 238 | Short syndrome | Enrichment | PIK3R1 | 1.93 |
| 239 | Congenital smooth muscle hamartoma, with or without hemihypertrophy | Enrichment | ACTB | 1.93 |
| 240 | Auriculocondylar syndrome 2a | Enrichment | PLCB4 | 1.93 |
| 241 | Night blindness, congenital stationary, type1i | Enrichment | GUCY2D | 1.93 |
| 242 | Ichthyosis, hystrix-like, with deafness | Enrichment | GJB2 | 1.93 |
| 243 | Oculodentodigital dysplasia, autosomal recessive | Enrichment | GJA1 | 1.93 |
| 244 | Cardiofaciocutaneous syndrome 2 | Enrichment | KRAS | 1.93 |
| 245 | Becker nevus syndrome | Enrichment | ACTB | 1.93 |
| 246 | Spastic paraplegia 44, autosomal recessive | Enrichment | GJC2 | 1.93 |
| 247 | Dystonia-deafness syndrome 1 | Enrichment | ACTB | 1.93 |
| 248 | Visceral neuropathy, familial, 3, autosomal dominant | Enrichment | ACTG2 | 1.93 |
| 249 | Cortical dysplasia, complex, with other brain malformations 7 | Enrichment | TUBB2B | 1.93 |
| 250 | Congenital myopathy 2b, severe infantile, autosomal recessive | Enrichment | ACTA1 | 1.93 |
| 251 | Moyamoya disease 6 with or without achalasia | Enrichment | GUCY1A1 | 1.93 |
| 252 | Immunodeficiency 36 with lymphoproliferation | Enrichment | PIK3R1 | 1.93 |
| 253 | Oocyte/zygote/embryo maturation arrest 23 | Enrichment | TUBA4A | 1.93 |
| 254 | Frontotemporal dementia and/or amyotrophic lateral sclerosis 9 | Enrichment | TUBA4A | 1.93 |
| 255 | Autosomal dominant familial visceral neuropathy | Enrichment | ACTG2 | 1.93 |
| 256 | Agammaglobulinemia 7, autosomal recessive | Enrichment | PIK3R1 | 1.93 |
| 257 | Hemangioma of liver | Enrichment | GJA4 | 1.93 |
| 258 | Erythrokeratodermia variabilis et progressiva 2 | Enrichment | GJB4 | 1.93 |
| 259 | Erythrokeratodermia variabilis et progressiva 3 | Enrichment | GJA1 | 1.93 |
| 260 | Facial palsy, congenital, with ptosis and velopharyngeal dysfunction | Enrichment | TUBB6 | 1.93 |
| 261 | Spinocerebellar ataxia 44 | Enrichment | GRM1 | 1.93 |
| 262 | Congenital myopathy 2c, severe infantile, autosomal dominant | Enrichment | ACTA1 | 1.93 |
| 263 | Gjc2-related late-onset primary lymphedema | Enrichment | GJC2 | 1.93 |
| 264 | Thrombocytopenia 8, with dysmorphic features and developmental delay | Enrichment | ACTB | 1.93 |
| 265 | Neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities | Enrichment | GRM7 | 1.93 |
| 266 | Moyamoya disease with early-onset achalasia | Enrichment | GUCY1A1 | 1.93 |
| 267 | Neuropathy with hearing impairment | Enrichment | GJB3 | 1.93 |
| 268 | Auriculocondylar syndrome 2b | Enrichment | PLCB4 | 1.93 |
| 269 | Macrothrombocytopenia, isolated, 2, autosomal dominant | Enrichment | TUBA8 | 1.93 |
| 270 | Adenoid ameloblastoma | Enrichment | CTNNB1 | 1.93 |
| 271 | Baraitser-winter syndrome | Enrichment | ACTB | 1.93 |
| 272 | Congenital myopathy 26 | Enrichment | TUBA4A | 1.93 |
| 273 | Spastic ataxia 11, autosomal dominant | Enrichment | TUBA4A | 1.93 |
| 274 | Amyotrophic lateral sclerosis type 22 | Enrichment | TUBA4A | 1.93 |
| 275 | Porokeratotic eccrine ostial and dermal duct nevus | Enrichment | GJB2 | 1.93 |
| 276 | Autosomal dominant nonsyndromic hearing loss 3a | Enrichment | GJB2 | 1.93 |
| 277 | Congenital pulmonary airway malformation | Enrichment | KRAS | 1.93 |
| 278 | Polymicrogyria with optic nerve hypoplasia | Enrichment | TUBA8 | 1.93 |
| 279 | Skin hemangioma | Enrichment | GJA4 | 1.93 |
| 280 | Zebra body myopathy | Enrichment | ACTA1 | 1.93 |
| 281 | Congenital smooth muscle hamartoma | Enrichment | ACTB | 1.93 |
| 282 | Developmental malformations-deafness-dystonia syndrome | Enrichment | ACTB | 1.93 |
| 283 | Actin-accumulation myopathy | Enrichment | ACTA1 | 1.93 |
| 284 | Chondromyxoid fibroma | Enrichment | GRM1 | 1.93 |
| 285 | Myopathic intestinal pseudoobstruction | Enrichment | ACTG2 | 1.93 |
| 286 | Egf-related primary hypomagnesemia with intellectual disability | Enrichment | EGF | 1.93 |
| 287 | Neurocutaneous melanocytosis | Enrichment | NRAS | 1.93 |
| 288 | Microcystic stromal tumor | Enrichment | CTNNB1 | 1.93 |
| 289 | Actg2 visceral myopathy | Enrichment | ACTG2 | 1.93 |
| 290 | Anterior segment dysgenesis | Enrichment | GJA8, ITPR1 | 1.89 |
| 291 | Mccune-albright syndrome | Enrichment | GNAS | 1.87 |
| 292 | Lynch syndrome 5 | Enrichment | RYR1 | 1.87 |
| 293 | Bronchopulmonary dysplasia | Enrichment | RYR1 | 1.87 |
| 294 | Cushing syndrome due to bilateral macronodular adrenocortical disease | Enrichment | GNAS | 1.87 |
| 295 | Melanoma of soft tissue | Enrichment | CREB1 | 1.87 |
| 296 | Spastic paraplegia 17, autosomal dominant | Enrichment | GNG3 | 1.83 |
| 297 | Thyroid cancer, nonmedullary, 1 | Enrichment | BRAF | 1.83 |
| 298 | Neurofibromatosis-noonan syndrome | Enrichment | MAP2K2 | 1.83 |
| 299 | Lipodystrophy, congenital generalized, type 2 | Enrichment | GNG3 | 1.83 |
| 300 | Chromosome 22q11.2 deletion syndrome, distal | Enrichment | MAPK1 | 1.83 |
| 301 | Carney complex variant | Enrichment | PRKAR1A | 1.83 |
| 302 | Arrhythmogenic right ventricular dysplasia, familial, 10 | Enrichment | PRKAR1A | 1.83 |
| 303 | Achromatopsia 4 | Enrichment | GNAI3 | 1.83 |
| 304 | Newborn respiratory distress syndrome | Enrichment | BRAF | 1.83 |
| 305 | Epidermolytic nevus | Enrichment | HRAS | 1.83 |
| 306 | Gingival fibromatosis | Enrichment | SOS1 | 1.83 |
| 307 | Male infertility due to gonadal dysgenesis or sperm disorder | Enrichment | SOS2 | 1.83 |
| 308 | Familial sick sinus syndrome | Enrichment | GNB2 | 1.83 |
| 309 | Chorea, benign hereditary | Enrichment | ADCY5 | 1.83 |
| 310 | Gillespie syndrome | Enrichment | ITPR1 | 1.81 |
| 311 | Nephrotic syndrome, type 3 | Enrichment | PLCE1 | 1.81 |
| 312 | Hypomyelination neuropathy-arthrogryposis syndrome | Enrichment | ADCY6 | 1.81 |
| 313 | Congenital myopathy 1a, autosomal dominant, with malignant hyperthermia | Enrichment | RYR1 | 1.75 |
| 314 | Myopathy, centronuclear, 2 | Enrichment | RYR1 | 1.75 |
| 315 | Sacral defect with anterior meningocele | Enrichment | RYR1 | 1.75 |
| 316 | Pseudohypoparathyroidism, type ib | Enrichment | GNAS | 1.75 |
| 317 | Intellectual developmental disorder, autosomal dominant 26 | Enrichment | RYR1 | 1.75 |
| 318 | Congenital myopathy 1a | Enrichment | RYR1 | 1.75 |
| 319 | Malignant hyperthermia | Enrichment | RYR1 | 1.75 |
| 320 | Early-onset nuclear cataract | Enrichment | GJA3, GJA8 | 1.73 |
| 321 | Diffuse cutaneous systemic sclerosis | Enrichment | CAV1 | 1.73 |
| 322 | Hemimegalencephaly | Enrichment | AKT3 | 1.73 |
| 323 | Spinocerebellar ataxia 15 | Enrichment | ITPR1 | 1.69 |
| 324 | Congenital myopathy 1b, autosomal recessive | Enrichment | RYR1 | 1.65 |
| 325 | Wilms tumor 5 | Enrichment | BRAF | 1.65 |
| 326 | Limited scleroderma | Enrichment | CAV1 | 1.65 |
| 327 | Myopathy, centronuclear, 1 | Enrichment | DNM2 | 1.65 |
| 328 | Atrial standstill 1 | Enrichment | GJA5 | 1.63 |
| 329 | Scoliosis, isolated 1 | Enrichment | MAPK7 | 1.63 |
| 330 | Spinocerebellar ataxia, x-linked 1 | Enrichment | GJB1 | 1.63 |
| 331 | Osteopathia striata with cranial sclerosis | Enrichment | CTNNB1 | 1.63 |
| 332 | Aortic aneurysm, familial thoracic 2 | Enrichment | ACTA2 | 1.63 |
| 333 | Congenital cataracts, facial dysmorphism, and neuropathy | Enrichment | GJA3 | 1.63 |
| 334 | Obsessive-compulsive disorder | Enrichment | HTR2A | 1.63 |
| 335 | Deafness, autosomal dominant 20 | Enrichment | ACTG1 | 1.63 |
| 336 | Smooth muscle dysfunction syndrome | Enrichment | ACTA2 | 1.63 |
| 337 | Encephalocraniocutaneous lipomatosis | Enrichment | KRAS | 1.63 |
| 338 | Aortic aneurysm, familial thoracic 6 | Enrichment | ACTA2 | 1.63 |
| 339 | Baraitser-winter syndrome 2 | Enrichment | ACTG1 | 1.63 |
| 340 | Duodenal atresia | Enrichment | GUCY2C | 1.63 |
| 341 | Hallermann-streiff syndrome | Enrichment | GJA1 | 1.63 |
| 342 | Cholestasis, progressive familial intrahepatic, 4 | Enrichment | TJP2 | 1.63 |
| 343 | Epiphyseal chondrodysplasia, miura type | Enrichment | NPR2 | 1.63 |
| 344 | Moyamoya disease 5 | Enrichment | ACTA2 | 1.63 |
| 345 | Spermatogenic failure 17 | Enrichment | PLCZ1 | 1.63 |
| 346 | Atrial fibrillation, familial, 11 | Enrichment | GJA5 | 1.63 |
| 347 | Syndactyly, type iii | Enrichment | GJA1 | 1.63 |
| 348 | Syndactyly, type v | Enrichment | GJA1 | 1.63 |
| 349 | Deafness, autosomal recessive 104 | Enrichment | GJB2 | 1.63 |
| 350 | Noonan syndrome 12 | Enrichment | RRAS2 | 1.63 |
| 351 | Childhood hepatocellular carcinoma | Enrichment | CTNNB1 | 1.63 |
| 352 | Craniometaphyseal dysplasia | Enrichment | GJA1 | 1.63 |
| 353 | Acromesomelic dysplasia 4 | Enrichment | PRKG2 | 1.63 |
| 354 | Acromesomelic dysplasia 1 | Enrichment | NPR2 | 1.63 |
| 355 | Ocular melanoma | Enrichment | PLCB4 | 1.63 |
| 356 | Diarrhea 6 | Enrichment | GUCY2C | 1.63 |
| 357 | Cortical dysplasia, complex, with other brain malformations 1 | Enrichment | TUBB3 | 1.63 |
| 358 | Juvenile nasopharyngeal angiofibroma | Enrichment | CTNNB1 | 1.63 |
| 359 | Congenital diarrhea 6 | Enrichment | GUCY2C | 1.63 |
| 360 | Intestinal obstruction in the newborn due to guanylate cyclase 2c deficiency | Enrichment | GUCY2C | 1.63 |
| 361 | Hereditary palmoplantar keratoderma | Enrichment | GJB2 | 1.63 |
| 362 | Teratoma | Enrichment | CTNNB1 | 1.63 |
| 363 | Intestinal obstruction | Enrichment | ACTG2 | 1.63 |
| 364 | Spastic ataxia | Enrichment | GJC2, ITPR1, TUBB3 | 1.62 |
| 365 | Myelofibrosis | Enrichment | SRC | 1.58 |
| 366 | Megacolon | Enrichment | AKT3 | 1.58 |
| 367 | Myeloma, multiple | Enrichment | BRAF, KRAS, PIK3R2 | 1.56 |
| 368 | Congenital stationary night blindness | Enrichment | GNB3, GRM6 | 1.53 |
| 369 | Lymphoma, non-hodgkin, familial | Enrichment | BRAF | 1.53 |
| 370 | Hypothyroidism | Enrichment | GNB1 | 1.53 |
| 371 | Choreatic disease | Enrichment | GNAO1 | 1.53 |
| 372 | Permanent neonatal diabetes mellitus | Enrichment | STAT3 | 1.53 |
| 373 | Spinocerebellar ataxia, autosomal recessive 16 | Enrichment | ITPR1 | 1.51 |
| 374 | Brachydactyly | Enrichment | GNAS | 1.51 |
| 375 | Hemolytic anemia | Enrichment | PKLR | 1.51 |
| 376 | Cardiomyopathy, familial hypertrophic, 4 | Enrichment | BRAF | 1.48 |
| 377 | Ventricular septal defect | Enrichment | BRAF | 1.48 |
| 378 | Cowden syndrome | Enrichment | AKT1 | 1.48 |
| 379 | Desmoid disease, hereditary | Enrichment | CTNNB1 | 1.46 |
| 380 | Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss | Enrichment | TUBB1 | 1.46 |
| 381 | Keratoderma, palmoplantar, with deafness | Enrichment | GJB2 | 1.46 |
| 382 | Pelizaeus-merzbacher disease | Enrichment | GJC2 | 1.46 |
| 383 | Diarrhea 3, secretory sodium, congenital, with or without other congenital anomalies | Enrichment | GUCY2C | 1.46 |
| 384 | Night blindness, congenital stationary, type 1b | Enrichment | GRM6 | 1.46 |
| 385 | Ifap syndrome 1, with or without bresheck syndrome | Enrichment | GJB2 | 1.46 |
| 386 | Charcot-marie-tooth disease, x-linked dominant, 1 | Enrichment | GJB1 | 1.46 |
| 387 | Hypercholanemia, familial 1 | Enrichment | TJP2 | 1.46 |
| 388 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi | Enrichment | PIK3R1 | 1.46 |
| 389 | Neurodevelopmental disorder with spastic diplegia and visual defects | Enrichment | CTNNB1 | 1.46 |
| 390 | Leukodystrophy, hypomyelinating, 2 | Enrichment | GJC2 | 1.46 |
| 391 | Epilepsy, familial focal, with variable foci 2 | Enrichment | NPR2 | 1.46 |
| 392 | Neonatal nephrocutaneous inflammatory syndrome | Enrichment | EGFR | 1.46 |
| 393 | Immunodeficiency 14a with lymphoproliferation, autosomal dominant | Enrichment | PIK3R1 | 1.46 |
| 394 | Anus, imperforate | Enrichment | CTNNB1 | 1.46 |
| 395 | Cortical dysplasia, complex, with other brain malformations 5 | Enrichment | TUBB2A | 1.46 |
| 396 | Exudative vitreoretinopathy 7 | Enrichment | CTNNB1 | 1.46 |
| 397 | Desmoid tumor | Enrichment | CTNNB1 | 1.46 |
| 398 | Immunodeficiency 14 | Enrichment | PIK3R1 | 1.46 |
| 399 | Polr3-related leukodystrophy | Enrichment | GUCY2D | 1.46 |
| 400 | Advanced sleep phase syndrome | Enrichment | CSNK1D | 1.46 |
| 401 | Sclerocornea | Enrichment | GJA8 | 1.46 |
| 402 | Neonatal inflammatory skin and bowel disease | Enrichment | EGFR | 1.46 |
| 403 | Pelizeaus-merzbacher spectrum disorder | Enrichment | GJC2 | 1.46 |
| 404 | Spastic paraplegia 4, autosomal dominant | Enrichment | GNAS | 1.45 |
| 405 | Multiple pterygium syndrome, lethal type | Enrichment | RYR1 | 1.45 |
| 406 | Congenital muscular dystrophy | Enrichment | RYR1 | 1.45 |
| 407 | Dilated cardiomyopathy | Enrichment | BRAF, RAF1 | 1.44 |
| 408 | Hydrops fetalis, nonimmune | Enrichment | ACTA1, HRAS | 1.43 |
| 409 | Melanoma | Enrichment | BRAF | 1.43 |
| 410 | Polymicrogyria | Enrichment | AKT3 | 1.43 |
| 411 | Tracheoesophageal fistula with or without esophageal atresia | Enrichment | ADD1 | 1.40 |
| 412 | Hydrops fetalis | Enrichment | RYR1 | 1.40 |
| 413 | Leukemia, acute lymphoblastic | Enrichment | GNB1 | 1.39 |
| 414 | Myelodysplastic syndrome | Enrichment | GNB1 | 1.39 |
| 415 | Movement disease | Enrichment | GNAO1 | 1.39 |
| 416 | Heritable pulmonary arterial hypertension | Enrichment | CAV1 | 1.39 |
| 417 | Specific learning disability | Enrichment | MAPK1 | 1.39 |
| 418 | Isolated tracheo-esophageal fistula | Enrichment | ADD1 | 1.36 |
| 419 | Meningioma | Enrichment | AKT1 | 1.35 |
| 420 | Nephrotic syndrome, type 1 | Enrichment | PLCE1 | 1.34 |
| 421 | Diffuse gastric and lobular breast cancer syndrome | Enrichment | KRAS | 1.34 |
| 422 | Nemaline myopathy 2 | Enrichment | ACTA1 | 1.34 |
| 423 | Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 | Enrichment | ACTG2 | 1.34 |
| 424 | Autoimmune lymphoproliferative syndrome | Enrichment | ACTA2 | 1.34 |
| 425 | Pilomatrixoma | Enrichment | CTNNB1 | 1.34 |
| 426 | Aminoacylase 1 deficiency | Enrichment | ACTB | 1.34 |
| 427 | Developmental and epileptic encephalopathy 12 | Enrichment | PLCB1 | 1.34 |
| 428 | Meconium ileus | Enrichment | GUCY2C | 1.34 |
| 429 | Short stature with nonspecific skeletal abnormalities 1 | Enrichment | NPR2 | 1.34 |
| 430 | Alazami syndrome | Enrichment | CTNNB1 | 1.34 |
| 431 | Lung sarcomatoid carcinoma | Enrichment | KRAS | 1.34 |
| 432 | Pilocytic astrocytoma | Enrichment | KRAS | 1.34 |
| 433 | Intermediate nemaline myopathy | Enrichment | ACTA1 | 1.34 |
| 434 | Pseudomyogenic hemangioendothelioma | Enrichment | ACTB | 1.34 |
| 435 | Aortic valve disease 1 | Enrichment | SOS1 | 1.32 |
| 436 | Osteoporosis | Enrichment | SRC | 1.29 |
| 437 | 46,xy partial gonadal dysgenesis | Enrichment | SOS1 | 1.29 |
| 438 | Wilms tumor 1 | Enrichment | BRAF | 1.26 |
| 439 | Rare genetic intellectual disability | Enrichment | GNAO1 | 1.26 |
| 440 | Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly | Enrichment | RYR1 | 1.24 |
| 441 | Clubfoot | Enrichment | RYR1 | 1.24 |
| 442 | Hypertrophic neuropathy of dejerine-sottas | Enrichment | GJB1 | 1.24 |
| 443 | Visceral myopathy 1 | Enrichment | ACTG2 | 1.24 |
| 444 | Exudative vitreoretinopathy 1 | Enrichment | CTNNB1 | 1.24 |
| 445 | Choroidal dystrophy, central areolar, 1 | Enrichment | GUCY2D | 1.24 |
| 446 | 3-methylglutaconic aciduria, type iii | Enrichment | GUCY2D | 1.24 |
| 447 | Congenital myopathy 3 with rigid spine | Enrichment | ACTA1 | 1.24 |
| 448 | Major depressive disorder | Enrichment | HTR2A | 1.24 |
| 449 | Night blindness, congenital stationary, type 1c | Enrichment | GRM6 | 1.24 |
| 450 | Cleft upper lip | Enrichment | GJA1 | 1.24 |
| 451 | Coloboma of choroid and retina | Enrichment | ACTG1 | 1.24 |
| 452 | Sensory peripheral neuropathy | Enrichment | GJB1 | 1.24 |
| 453 | Severe congenital nemaline myopathy | Enrichment | ACTA1 | 1.24 |
| 454 | Rhabdomyosarcoma | Enrichment | HRAS | 1.23 |
| 455 | Congenital nervous system abnormality | Enrichment | GNAO1, GNB5 | 1.22 |
| 456 | Nervous system disease | Enrichment | GNAO1, GNB5 | 1.22 |
| 457 | Congenital long qt syndrome | Enrichment | ITPR3 | 1.22 |
| 458 | Melanoma, cutaneous malignant 1 | Enrichment | BRAF | 1.21 |
| 459 | Cleft palate, isolated | Enrichment | GNB1 | 1.21 |
| 460 | Dandy-walker syndrome | Enrichment | BRAF | 1.21 |
| 461 | Dystonia | Enrichment | GJC2, GNB1 | 1.20 |
| 462 | Autism spectrum disorder | Enrichment | GNB1, MAP2K1 | 1.20 |
| 463 | Congenital myopathy 4a, autosomal dominant | Enrichment | RYR1 | 1.18 |
| 464 | Heart, malformation of | Enrichment | MAPK1 | 1.18 |
| 465 | Early infantile developmental and epileptic encephalopathy | Enrichment | GNAO1 | 1.18 |
| 466 | Non-syndromic genetic deafness | Enrichment | ACTG1, GJB2 | 1.18 |
| 467 | Melanoma, uveal | Enrichment | PLCB4 | 1.17 |
| 468 | Dystonia 11, myoclonic | Enrichment | DRD2 | 1.17 |
| 469 | Branchiootorenal syndrome 1 | Enrichment | TJP2 | 1.17 |
| 470 | Cowden syndrome 1 | Enrichment | EGFR | 1.17 |
| 471 | Weyers acrofacial dysostosis | Enrichment | CTNNB1 | 1.17 |
| 472 | Cerebellar ataxia, impaired intellectual development, and dysequilibrium syndrome 1 | Enrichment | TUBB2B | 1.17 |
| 473 | Deafness, autosomal recessive 12 | Enrichment | GJB2 | 1.17 |
| 474 | Intestinal pseudo-obstruction | Enrichment | ACTG2 | 1.17 |
| 475 | Pain disorder | Enrichment | GJB1 | 1.17 |
| 476 | Familial hypercholanemia | Enrichment | TJP2 | 1.17 |
| 477 | Early-onset sutural cataract | Enrichment | GJA8 | 1.17 |
| 478 | Typical nemaline myopathy | Enrichment | ACTA1 | 1.17 |
| 479 | Arrhythmogenic right ventricular cardiomyopathy | Enrichment | RYR1 | 1.16 |
| 480 | Multiple sclerosis | Enrichment | ITPR1 | 1.16 |
| 481 | Centronuclear myopathy | Enrichment | DNM2 | 1.12 |
| 482 | Beckwith-wiedemann syndrome | Enrichment | RYR1 | 1.11 |
| 483 | Neuromuscular disease | Enrichment | RYR1 | 1.11 |
| 484 | Squamous cell carcinoma, head and neck | Enrichment | EGFR | 1.10 |
| 485 | Polymicrogyria, bilateral perisylvian, x-linked | Enrichment | TUBB2B | 1.10 |
| 486 | Branchiootorenal syndrome | Enrichment | TJP2 | 1.10 |
| 487 | Childhood-onset nemaline myopathy | Enrichment | ACTA1 | 1.10 |
| 488 | Overgrowth syndrome | Enrichment | PIK3R1 | 1.10 |
| 489 | Attention deficit-hyperactivity disorder | Enrichment | GNB5 | 1.10 |
| 490 | Leukemia, acute myeloid | Enrichment | KRAS, NRAS | 1.10 |
| 491 | Esophageal atresia/tracheoesophageal fistula | Enrichment | ADD1 | 1.09 |
| 492 | Congenital myopathy | Enrichment | RYR1 | 1.09 |
| 493 | Cardiomyopathy, familial hypertrophic, 1 | Enrichment | RAF1 | 1.06 |
| 494 | Developmental and epileptic encephalopathy 1 | Enrichment | GNAO1 | 1.05 |
| 495 | Leber congenital amaurosis 1 | Enrichment | GUCY2D | 1.05 |
| 496 | Exudative vitreoretinopathy | Enrichment | CTNNB1 | 1.05 |
| 497 | Hypoplastic left heart syndrome | Enrichment | GJA1 | 1.05 |
| 498 | Cataract - microcornea syndrome | Enrichment | GJA8 | 1.05 |
| 499 | Early-onset posterior polar cataract | Enrichment | GJA3 | 1.05 |
| 500 | Optic atrophy plus syndrome | Enrichment | GUCY2D, TUBB6 | 1.03 |
| 501 | West syndrome | Enrichment | CSNK1E, PLCB1 | 1.03 |
| 502 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | ACTA2, PRKG1 | 1.03 |
| 503 | Hereditary breast carcinoma | Enrichment | AKT1, KRAS | 1.03 |
| 504 | Strabismus | Enrichment | GNB1 | 1.01 |
| 505 | Focal segmental glomerulosclerosis | Enrichment | PLCE1 | 1.01 |
| 506 | Developmental and epileptic encephalopathy 14 | Enrichment | PLCB1 | 1.00 |
| 507 | Bilateral perisylvian polymicrogyria | Enrichment | TUBB2B | 1.00 |
| 508 | Primary biliary cholangitis | Enrichment | TJP2 | 1.00 |
| 509 | Scoliosis | Enrichment | RYR1 | 0.99 |
| 510 | Thrombocytopenia | Enrichment | SRC, TUBB1 | 0.96 |
| 511 | Cat eye syndrome | Enrichment | ACTG1 | 0.95 |
| 512 | Nemaline myopathy | Enrichment | ACTA1 | 0.95 |
| 513 | Autosomal non-syndromic agammaglobulinemia | Enrichment | PIK3R1 | 0.95 |
| 514 | Autosomal dominant non-syndromic intellectual disability | Enrichment | GNB1, PPP3CA | 0.93 |
| 515 | Familial hypertrophic cardiomyopathy | Enrichment | RAF1 | 0.93 |
| 516 | Left ventricular noncompaction | Enrichment | RAF1 | 0.91 |
| 517 | Developmental and epileptic encephalopathy | Enrichment | GNAO1 | 0.90 |
| 518 | Congenital hypothyroidism | Enrichment | TUBB1 | 0.88 |
| 519 | Complex neurodevelopmental disorder | Enrichment | GNB2, PPP2CA | 0.87 |
| 520 | Cerebral palsy | Enrichment | GNB1 | 0.86 |
| 521 | Myopathy | Enrichment | DNM2 | 0.85 |
| 522 | Protein-deficiency anemia | Enrichment | NRAS | 0.85 |
| 523 | Charcot-marie-tooth disease | Enrichment | DNM2 | 0.84 |
| 524 | Long qt syndrome 1 | Enrichment | ITPR3 | 0.84 |
| 525 | Type 2 diabetes mellitus | Enrichment | AKT2 | 0.83 |
| 526 | Medulloblastoma | Enrichment | CTNNB1 | 0.82 |
| 527 | Cone-rod dystrophy 6 | Enrichment | GUCY2D | 0.82 |
| 528 | Fetal akinesia deformation sequence 1 | Enrichment | RYR1 | 0.81 |
| 529 | Genetic steroid-resistant nephrotic syndrome | Enrichment | PLCE1 | 0.79 |
| 530 | Lynch syndrome | Enrichment | KRAS | 0.79 |
| 531 | Gliosarcoma | Enrichment | EGFR | 0.76 |
| 532 | Distal arthrogryposis | Enrichment | RYR1 | 0.76 |
| 533 | Familial isolated dilated cardiomyopathy | Enrichment | RAF1 | 0.74 |
| 534 | Cataract 44 | Enrichment | GJA8 | 0.74 |
| 535 | Polycystic liver disease | Enrichment | CTNNB1 | 0.74 |
| 536 | Giant cell glioblastoma | Enrichment | EGFR | 0.74 |
| 537 | Autosomal dominant polycystic liver disease | Enrichment | CTNNB1 | 0.74 |
| 538 | Nephrotic syndrome | Enrichment | PLCE1 | 0.70 |
| 539 | Craniosynostosis | Enrichment | NPR2 | 0.68 |
| 540 | Hepatoblastoma | Enrichment | CTNNB1 | 0.66 |
| 541 | Hepatocellular carcinoma | Enrichment | CTNNB1 | 0.64 |
| 542 | Myocardial infarction | Enrichment | GUCY1A1 | 0.64 |
| 543 | Microphthalmia | Enrichment | GJA8 | 0.64 |
| 544 | Rare genetic deafness | Enrichment | ACTG1, GJB2 | 0.63 |
| 545 | Ear malformation | Enrichment | GJB2 | 0.61 |
| 546 | Familial atrial fibrillation | Enrichment | GJA5 | 0.61 |
| 547 | Cone dystrophy | Enrichment | GUCY2D | 0.61 |
| 548 | Primary ciliary dyskinesia | Enrichment | PRKAR1B | 0.60 |
| 549 | Pancreatic cancer | Enrichment | KRAS | 0.59 |
| 550 | Tetralogy of fallot | Enrichment | GJA5 | 0.58 |
| 551 | Leber plus disease | Enrichment | GRM6, GUCY2D | 0.51 |
| 552 | Connective tissue disease | Enrichment | ACTA2 | 0.50 |
| 553 | Peripheral nervous system disease | Enrichment | GJB1 | 0.50 |
| 554 | Neuropathy | Enrichment | GJB1 | 0.50 |
| 555 | Cakut | Enrichment | ACTG1 | 0.48 |
| 556 | Benign epilepsy with centrotemporal spikes | Enrichment | PLCB1 | 0.42 |
| 557 | Inherited cancer-predisposing syndrome | Enrichment | PRKAR1A | 0.41 |
| 558 | Centralopathic epilepsy | Enrichment | PLCB1 | 0.40 |
| 559 | Gastric cancer | Enrichment | KRAS | 0.40 |
| 560 | Sensorineural hearing loss | Enrichment | GJB2 | 0.36 |
| 561 | Hereditary breast ovarian cancer syndrome | Enrichment | KRAS | 0.32 |
| 562 | Undetermined early-onset epileptic encephalopathy | Enrichment | PPP3CA | 0.32 |
| 563 | Autosomal recessive non-syndromic intellectual disability | Enrichment | GRM7 | 0.30 |
| 564 | Schizophrenia | Enrichment | HTR2A | 0.30 |
| 565 | Deafness, autosomal recessive | Enrichment | GJB2 | 0.28 |
| 566 | Autosomal recessive nonsyndromic deafness | Enrichment | GJB2 | 0.28 |
| 567 | Cone-rod dystrophy 2 | Enrichment | GUCY2D | 0.26 |
| 568 | Hereditary retinal dystrophy | Enrichment | GRM6, GUCY2D | 0.07 |
| 569 | Fundus dystrophy | Enrichment | GRM6, GUCY2D | 0.07 |
| 570 | Retinitis pigmentosa | Enrichment | GUCY2D | 0.04 |